A-276575

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-276575
Drug Alias NameA-276575
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor modulatorsProstaglandin E2 inhibitorsInterleukin-1 receptor antagonists +[4] 
TargetsAromataseGlucocorticoid receptorProstaglandin E2 +[4] 
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A